Left Ventricular Reverse Remodelling Predicts Long-Term Outcomes in Patients with Functional Mitral Regurgitation Undergoing Mitraclip Therapy: Results from a Multicentre Registry
- 13 December 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 21 (2) , 196-204
Abstract
Aims To explore whether left ventricular reverse remodelling (LVRR) is a predictor of outcomes in patients with functional mitral regurgitation (FMR) undergoing MitraClip procedure. Methods and results We analysed 184 consecutive patients with FMR who underwent successful MitraClip procedure. LVRR was defined as a reduction in left ventricular end‐systolic volume ≥ 10% from baseline to 6 months. LVRR was observed in 79 (42.9%) patients. Compared with non‐LVRR, LVRR patients were more likely to be females, less likely to have an ischaemic aetiology of mitral regurgitation or a prior (P = 0.039), freedom from HF hospitalization (77.2% vs. 60%, P = 0.020), and freedom from the composite endpoint (cardiovascular mortality or HF hospitalization) (74.7% vs. 55.2%; P = 0.012) were observed in LVRR vs. non‐LVRR patients at 2‐year follow‐up. LVRR was associated with a significant reduction of the adjusted relative risk of mortality, HF hospitalization and composite endpoint [hazard ratio (HR) 0.44; 95% confidence interval (CI) 0.20–0.96, P = 0.040; HR 0.55; 95% CI 0.32–0.97, P = 0.038; and HR 0.54; 95% CI 0.32–0.92, P = 0.023, respectively]. Female gender, absence of diabetes, freedom from prior HF hospitalization, non‐ischaemic aetiology of mitral regurgitation, and left ventricular end‐diastolic diameter < 75 mm were found to be independent predictors of LVRR. Conclusions Left ventricular reverse remodelling is associated with better long‐term outcomes in patients with FMR successfully treated with MitraClip. Independent predictors of LVRR are: gender, diabetes, recent HF hospitalization, mitral regurgitation aetiology, and left ventricular dimensions.Keywords
This publication has 29 references indexed in Scilit:
- Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization TherapyDiabetes Care, 2013
- Correction of Mitral Regurgitation in Nonresponders to Cardiac Resynchronization Therapy by MitraClip Improves Symptoms and Promotes Reverse RemodelingJACC, 2011
- Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudyEuropean Heart Journal, 2011
- Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to OutcomeCirculation, 2010
- The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapyJournal of Diabetes and its Complications, 2009
- Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter studyEuropean Heart Journal, 2008
- Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic DysfunctionCirculation, 2007
- Effect of Cardiac Resynchronization on Morbidity and Mortality of Diabetic Patients With Severe Heart FailureDiabetes Care, 2007
- Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization TherapyCirculation, 2005
- Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the ELITE ventricular function substudyAmerican Heart Journal, 2000